by Karl Voigt
Patients who are taking the pain medication Opana are now facing its manufacturer’s withdrawal of the medication from the market.
Earler this year, the US Food and Drug Administration (FDA) concluded that Opana ER “exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death”. The drug has been available since 2006.
The manufacturer, Endo Pharmaceuticals based in Malvern PA, has been withdrawing the medication from pharmacies since June. Supplies are nearly gone and patients should consult with their physicians for a suitable alternative.
The FDA has made no secret that they intend to review other opioid painkillers.